On the existence of cardiomesenchymal stem cells
José R Navarro-Betancourt1, Salomón Hernández1
1Molecular Biology Department, School of Medicine, Universidad Panamericana, Mexico.
Insights
Myocardium-resident cardiac stem cells are ideal for cardiac regeneration but limited in supply. Researchers hypothesize that a novel cardiomesenchymal stem cell (CMSC) population could offer a solution for cardiac repair.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Myocardium-resident cardiac stem cells are the most effective for cardiac regeneration but are scarce for therapeutic use.
- Mesenchymal stem cells exhibit broad differentiation potential but lack specificity for cardiac lineage, limiting their efficiency in cardiac regeneration therapies.
- The heterogeneity of mesenchymal stem cells suggests the possibility of identifying subpopulations with inherent cardiac differentiation capacity.
Purpose of the Study:
- To investigate the potential of a specific stem cell subpopulation for cardiac regeneration.
- To identify a stem cell population combining cardiac and mesenchymal stem cell characteristics for enhanced therapeutic value.
Main Methods:
- Evaluating surface marker expression to identify stem cell subpopulations with cardiac differentiation potential.
- Hypothesizing the existence and characteristics of a novel cardiomesenchymal stem cell (CMSC) population.
Main Results:
- Cardiac stem cells are the most efficient for cardiac regeneration.
- Mesenchymal stem cells have limited efficiency for cardiac regeneration due to differentiation challenges.
- A potential exists to identify specific mesenchymal stem cell subpopulations with cardiac differentiation capacity based on surface markers.
Conclusions:
- Cardiomesenchymal stem cells (CMSCs), possessing both cardiac and mesenchymal stem cell markers, are hypothesized to be ideal candidates for cardiac regeneration therapy.
- Identifying and isolating CMSCs could overcome the limitations of current stem cell therapies for cardiac repair.
Abstract:
The most efficient cells for cardiac regeneration are myocardium-resident cardiac stem cells. However, the limited availability of these cells restricts their utility for cardiac cellular therapy. Mesenchymal stem cells can differentiate into a wide variety of tissues, but it is not simple to accurately direct cell differentiation into a specific lineage, such as cardiac tissue; this renders a low efficiency for cardiac regeneration therapy. Given the heterogeneity of mesenchymal stem cells, it may be possible to find specific stem cell subpopulations with a definite differentiation capacity toward cardiac lineage. A parameter to assess cardiac differentiation specificity could be surface marker expression; a population with an immunophenotype similar to cardiac stem cells may have a superior therapeutic value than unsorted mesenchymal stem cells. We hypothesize the existence of a cell line that combines the expression of cardiac stem cell surface markers with those of mesenchymal stem cells, a suitable name for this population is cardiomesenchymal stem cells (CMSC); such cells would be ideal for cardiac regeneration.
Related Concept Videos
Mesenchymal Stem Cells
Multipotency of Hematopoietic Stem Cells
Satellite Stem Cells and Muscular Dystrophy


